W17 (Sumatriptan Succinate 25 mg)
Pill with imprint W17 is White, Round and has been identified as Sumatriptan Succinate 25 mg. It is supplied by Hikma Pharmaceutical.
Sumatriptan is used in the treatment of cluster headaches; migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Sumatriptan 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W17
Sumatriptan Succinate
- Imprint
- W17
- Strength
- 25 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimigraine agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Hikma Pharmaceutical
- National Drug Code (NDC)
- 59115-0076
Related Images for "W17"
More about sumatriptan
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 479 Reviews
- Drug class: antimigraine agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Sumatriptan oral/nasal
- Sumatriptan (Advanced Reading)
- Sumatriptan Nasal, Oral, Subcutaneous (Advanced Reading)
- Sumatriptan Subcutaneous (Advanced Reading)
- ... +4 more
- Other brands
- Imitrex, Tosymra, Imitrex Statdose, Sumavel DosePro, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.